Not applicableEnded earlyNCT06785103What this trial is testingIBIS Megastudy- PilotWho this might be right forHIV University of California, San Francisco 98
Not applicableStudy completedNCT05371327What this trial is testingCommunity Solutions to Adolescent Research Consent - Minor Consent for Biomedical HIV ResearchWho this might be right forInformed ConsentHIV Infections Indiana University 128
Early research (Phase 1)Study completedNCT01479361What this trial is testingAntiretroviral Drug Interaction Study in Volunteers With HIVWho this might be right forHIVPCPToxoplasmosis National Institutes of Health Clinical Center (CC) 36
Early research (Phase 1)Study completedNCT00002373What this trial is testingThe Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected PatientsWho this might be right forCytomegalovirus InfectionsHIV Infections Glaxo Wellcome 56
Large-scale testing (Phase 3)Study completedNCT03656783What this trial is testingEffects of Biktarvy on CFR in Stable HIV PatientsWho this might be right forHIV Brigham and Women's Hospital 25
Large-scale testing (Phase 3)Study completedNCT02660905What this trial is testingHIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionWho this might be right forHuman Immunodeficiency VirusHepatitis C, Chronic Ottawa Hospital Research Institute 25
Not applicableStudy completedNCT01804907What this trial is testingFeasibility of Non-pharmacological Insomnia Therapy in People Living With HIVWho this might be right forInsomniaSleep Efficiency Duke University 36
Not applicableStudy completedNCT01048671What this trial is testingManagement of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)Who this might be right forHIV Infections Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT05016232What this trial is testingAdaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender WomenWho this might be right forPrevention University of California, Los Angeles 123
Not applicableStudy completedNCT01886404What this trial is testingEFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected PatientsWho this might be right forHIV Infection University of Nebraska 30
Testing effectiveness (Phase 2)Study completedNCT00333684What this trial is testingSafety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-AlcamidWho this might be right forHuman Immunodeficiency VirusFacial Lipoatrophy Canadian Immunodeficiency Research Collaborative 36
Not applicableWithdrawnNCT03964584What this trial is testingEvaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real LifeWho this might be right forHIV+ Patients Fondation Ophtalmologique Adolphe de Rothschild
Testing effectiveness (Phase 2)Study completedNCT00461552What this trial is testingTherapeutic Approaches to HAART-Induced LipodystrophyWho this might be right forHIV InfectionsLipodystrophy University of Texas Southwestern Medical Center 23
Not applicableStudy completedNCT01413152What this trial is testingResidual Risk Assessment Of HIV TransmissionWho this might be right forHIV Infection French National Agency for Research on AIDS and Viral Hepatitis 167
Post-approval studies (Phase 4)Study completedNCT02547844What this trial is testingEvolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With AtriplaWho this might be right forHIV-1 Hospital Universitari Vall d'Hebron Research Institute 30
Not applicableStudy completedNCT00006444What this trial is testingThe Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected WomenWho this might be right forHIV InfectionsPapilloma National Institute of Allergy and Infectious Diseases (NIAID) 160
Testing effectiveness (Phase 2)Study completedNCT00035893What this trial is testingThe Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAARTWho this might be right forHIV SeropositivityHIV Infection AIM ImmunoTech Inc. 40
Not applicableStudy completedNCT05084716What this trial is testingPre-Exposure Prophylaxis (PrEP) Provision for Ugandan FisherfolkWho this might be right forHIV RAND 885
Testing effectiveness (Phase 2)Study completedNCT00008463What this trial is testingA Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)Who this might be right forHIV InfectionsHepatitis C National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT00001133What this trial is testingSafety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or SaquinavirWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 50